HCA250117C260000
- 37.00
- 0.000.00%
HCA Healthcare Newsroom
HCA Healthcare Is Maintained at Overweight by Keybanc
HCA Healthcare Analyst Ratings
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Cuts Target Price to $370
Truist Financial Maintains HCA Healthcare(HCA.US) With Buy Rating, Announces Target Price $390
HCA Healthcare Analyst Ratings
Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $390
Optimistic Outlook and Buy Rating for HCA Healthcare Driven by Strategic Initiatives and Market Dynamics
HCA Healthcare Price Target Cut to $355.00/Share From $406.00 by Morgan Stanley
HCA Healthcare Is Maintained at Equal-Weight by Morgan Stanley
Goldman Sachs Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $319
Morgan Stanley Maintains HCA Healthcare(HCA.US) With Hold Rating, Cuts Target Price to $355
HCA Healthcare Analyst Ratings
JP Morgan Assumes HCA Healthcare at Neutral, Announces Price Target of $380
Goldman Sachs Adjusts Price Target on HCA Healthcare to $319 From $359, Maintains Neutral Rating
HCA Healthcare (HCA) Was Downgraded to a Sell Rating at Wells Fargo
J.P. Morgan Maintains HCA Healthcare(HCA.US) With Hold Rating, Raises Target Price to $380
HCA Healthcare Cut to Underweight From Equal-Weight by Wells Fargo
Wells Fargo Downgrades HCA Healthcare(HCA.US) to Sell Rating, Cuts Target Price to $320
Wells Fargo Downgrades HCA Healthcare to Underweight From Equalweight, Adjusts Price Target to $320 From $400
HCA Healthcare Analyst Ratings